Fundies.
English

Segment disclosures

Company overview

MAJESCO ENTERTAINMENT CO

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

8 dimension combinations 66 retained observations 25 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Contract Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=COOL:ContractServicesMember
PeriodValueUnitFiledEvidence
2017-11-01 – 2018-10-31874000 USD20190114Open filing evidence

Regenerative Medicine

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cool:RegenerativeMedicineMember
PeriodValueUnitFiledEvidence
2016-11-01 – 2017-01-310 USD20170316Open filing evidence
2015-11-01 – 2016-01-310 USD20170316Open filing evidence

Regenerative Medicine

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=COOL:RegenerativeMedicineMember
PeriodValueUnitFiledEvidence
2017-11-01 – 2018-10-31689000 USD20190114Open filing evidence
2018-05-01 – 2018-07-31244000 USD20180914Open filing evidence
2017-11-01 – 2018-07-31260000 USD20180914Open filing evidence

Veterinary Sciences

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=COOL:VeterinarySciencesMember
PeriodValueUnitFiledEvidence
2018-05-01 – 2018-07-31172000 USD20180914Open filing evidence
2017-11-01 – 2018-07-31172000 USD20180914Open filing evidence

Video Games

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cool:VideoGamesMember
PeriodValueUnitFiledEvidence
2016-11-01 – 2017-01-31156000 USD20170316Open filing evidence
2015-11-01 – 2016-01-31591000 USD20170316Open filing evidence

Video Games

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=COOL:VideoGamesMember
PeriodValueUnitFiledEvidence
2017-02-01 – 2017-04-30259000 USD20170609Open filing evidence
2016-11-01 – 2017-04-30415000 USD20170609Open filing evidence
2016-02-01 – 2016-04-30412000 USD20170609Open filing evidence
2015-11-01 – 2016-04-301003000 USD20170609Open filing evidence

Contract Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=PTE:ContractServicesMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-31814000 USD20230327Open filing evidence
2022-01-01 – 2022-09-30814000 USD20221110Open filing evidence
2022-04-01 – 2022-06-3073000 USD20220811Open filing evidence
2022-01-01 – 2022-06-30814000 USD20220811Open filing evidence
2022-01-01 – 2022-03-31741000 USD20230512Open filing evidence
2021-01-01 – 2021-12-316328000 USD20230327Open filing evidence
2021-07-01 – 2021-09-301116000 USD20221110Open filing evidence
2021-01-01 – 2021-09-305438000 USD20221110Open filing evidence
2021-04-01 – 2021-06-301342000 USD20220811Open filing evidence
2021-01-01 – 2021-06-304322000 USD20220811Open filing evidence
2021-01-01 – 2021-03-312980000 USD20220516Open filing evidence
2020-01-01 – 2020-12-316396000 USD20220330Open filing evidence
2020-07-01 – 2020-09-302181000 USD20211110Open filing evidence
2020-01-01 – 2020-09-304008000 USD20211110Open filing evidence
2020-04-01 – 2020-06-301322000 USD20210812Open filing evidence
2020-01-01 – 2020-06-301827000 USD20210812Open filing evidence
2020-01-01 – 2020-03-31505000 USD20210513Open filing evidence
2019-01-01 – 2019-12-313299000 USD20210330Open filing evidence
2019-07-01 – 2019-09-30556000 USD20201109Open filing evidence
2019-01-01 – 2019-09-302546000 USD20201109Open filing evidence
2019-04-01 – 2019-06-30822000 USD20200806Open filing evidence
2019-01-01 – 2019-06-301990000 USD20200806Open filing evidence
2019-01-01 – 2019-03-311168000 USD20200511Open filing evidence
2018-11-01 – 2018-12-31463000 USD20200312Open filing evidence
2017-11-01 – 2018-10-31874000 USD20200312Open filing evidence
2018-07-01 – 2018-09-30528000 USD20191112Open filing evidence
2018-01-01 – 2018-09-30659000 USD20191112Open filing evidence
2018-04-01 – 2018-06-30131000 USD20190808Open filing evidence
2018-01-01 – 2018-06-30131000 USD20190808Open filing evidence

Regenerative Medicine

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=PTE:RegenerativeMedicineMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-313076000 USD20230327Open filing evidence
2021-01-01 – 2021-09-302924000 USD20221110Open filing evidence
2021-04-01 – 2021-06-301195000 USD20220811Open filing evidence
2021-01-01 – 2021-06-302924000 USD20220811Open filing evidence
2021-01-01 – 2021-03-311729000 USD20220516Open filing evidence
2020-01-01 – 2020-12-313730000 USD20220330Open filing evidence
2020-07-01 – 2020-09-301156000 USD20211110Open filing evidence
2020-01-01 – 2020-09-302528000 USD20211110Open filing evidence
2020-04-01 – 2020-06-30944000 USD20210812Open filing evidence
2020-01-01 – 2020-06-301372000 USD20210812Open filing evidence
2020-01-01 – 2020-03-31428000 USD20210513Open filing evidence
2019-01-01 – 2019-12-312353000 USD20210330Open filing evidence
2019-07-01 – 2019-09-30839000 USD20201109Open filing evidence
2019-01-01 – 2019-09-301640000 USD20201109Open filing evidence
2019-04-01 – 2019-06-30504000 USD20200806Open filing evidence
2019-01-01 – 2019-06-30801000 USD20200806Open filing evidence
2019-01-01 – 2019-03-31297000 USD20200511Open filing evidence
2018-11-01 – 2018-12-31210000 USD20200312Open filing evidence
2017-11-01 – 2018-10-31689000 USD20200312Open filing evidence
2018-07-01 – 2018-09-30197000 USD20191112Open filing evidence
2018-01-01 – 2018-09-30389000 USD20191112Open filing evidence
2018-04-01 – 2018-06-30189000 USD20190808Open filing evidence
2018-01-01 – 2018-06-30192000 USD20190808Open filing evidence